Pittsburgh Undergraduate Research Diversity Program (PURDIP)

匹兹堡本科生研究多样性计划(PURDIP)

基本信息

项目摘要

ABSTRACT The goal of the Pittsburgh Undergraduate Research Diversity Program (PURDIP) is to catalyze the training and career development of underrepresented minority undergraduate students in research, to enhance the diversity of the biomedical, behavioral, and clinical research workforce in the mission areas of importance to the NHLBI. This goal will be achieved through the provision of an intensive summer research educational experience in innovative technologies and conceptual paradigms related to heart, lung, blood and sleep-related science at the University of Pittsburgh. The focus of PURDIP is knowledge in Fundamentals of Biomedical and Behavioral Research and Health Disparity, Mentored Research Projects and Learning Skills. Its objective is to help the students discover their passion for research in heart, lung, sleep and blood science, provide hands-on research experience to trainees to help them to better understand the biomedical, behavioral and clinical research profession, and finally to motivate the trainees to continue on to graduate and other health professions careers. Over 70 University of Pittsburgh academic faculty from the broad disciplines of cardiology, hematology/oncology, vascular biology, molecular biology, pharmacology, coagulation and thrombosis, transfusion medicine, regenerative medicine and sleep at the University of Pittsburgh are available to provide a broad array of basic, behavioral, translational and clinical research topics and study patient populations to carry out this project. The program is focused on multiple areas of heart, lung, blood and sleep research including hemolysis-related vascular disorders, sickle cell disease, pulmonary hypertension, cardiac imaging, and cardiovascular health outcomes. Training will incorporate the learning of cutting edge methodologies that is applied to a clinical problem, leading to potentially novel therapeutic approaches or clinical studies in patients. Trainees will be paired up with one clinical investigator and one basic or behavioral investigator to give them a broad perspective on health-related research.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles Richard Jonassaint其他文献

Charles Richard Jonassaint的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles Richard Jonassaint', 18)}}的其他基金

Designing an Implementation Strategy for Delivering Routine Mental Health Screening and Treatment for Adolescents and Adults with Sickle Cell Disease
设计为患有镰状细胞病的青少年和成人提供常规心理健康筛查和治疗的实施策略
  • 批准号:
    10264093
  • 财政年份:
    2020
  • 资助金额:
    $ 12.2万
  • 项目类别:
Painimation: An innovative, technology-based method for measuring pain quality, location and severity in sickle cell disease
Painimation:一种基于技术的创新方法,用于测量镰状细胞病的疼痛质量、位置和严重程度
  • 批准号:
    9649363
  • 财政年份:
    2018
  • 资助金额:
    $ 12.2万
  • 项目类别:
Geospatial and Ecological momentary assessment Technology and Activity Engagement for at-risk youth
地理空间和生态临时评估 高危青少年的技术和活动参与
  • 批准号:
    10435008
  • 财政年份:
    2018
  • 资助金额:
    $ 12.2万
  • 项目类别:
Geospatial and Ecological momentary assessment Technology and Activity Engagement for at-risk youth
地理空间和生态临时评估 高危青少年的技术和活动参与
  • 批准号:
    10631235
  • 财政年份:
    2018
  • 资助金额:
    $ 12.2万
  • 项目类别:
Using Technology to Deliver Evidence-Based Interventions for Pain to Patients with Sickle Cell Disease
利用技术为镰状细胞病患者提供循证疼痛干预措施
  • 批准号:
    9224339
  • 财政年份:
    2017
  • 资助金额:
    $ 12.2万
  • 项目类别:

相似海外基金

Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7462657
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    8013895
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7755368
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Drug Abuse and Crime Across the Life Course in an African American Population
非裔美国人一生中的药物滥用和犯罪
  • 批准号:
    7586197
  • 财政年份:
    2008
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10132461
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10331060
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10597891
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
Molecular and Genetic Signatures of Perturbed Diabetic Pathways with Hepatitis C Virus infection and Co-morbidity Risks in African American Population
丙型肝炎病毒感染引起的糖尿病通路紊乱的分子和遗传特征以及非洲裔美国人的共病风险
  • 批准号:
    10178913
  • 财政年份:
    1997
  • 资助金额:
    $ 12.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了